CHESTCOVID-19 Resource Center

COVID-19 Resource Center

Featured Content

  • Access key information at a glance with our infographics on post-intensive care syndrome, antimicrobial stewardship, asthma and COVID-19, and more. Clinical Resources
  • Read a comprehensive overview of the literature on aerosol drug delivery in the COVID-19 era. Guidelines, Statements, and Research
  • Watch recordings of recent webinars on coma science and sedation practices in patients with COVID-19, PTSD and moral distress in health care providers on the front lines, and lessons learned from past pandemics. Advice From the Front Lines



Clinical Resources

Find expert-vetted articles and infographics on the clinical management of COVID-19 patients, ICU administration, procedures, supply chain issues, and treatment.


Advice From the Front Lines

Watch recordings of webinars featuring CHEST experts discussing COVID-19 hot topics.


Guidelines, Statements, and Research

Access guidelines, statements, and key research related to the management of patients with COVID-19.


Voices From the Community

Hear directly from CHEST frontline physicians on their experiences navigating the pandemic.


On-Demand e-Learning

Access free e-learning modules from CHEST experts on ARDS, mechanical ventilation, hypoxemic respiratory failure, and more.


CHEST Journal

Find the latest research on the COVID-19 pandemic published in the journal CHEST®.

COVID-19 burnout

Burnout and Moral Distress Among Frontline Clinicians During the COVID-19 Pandemic

The COVID-19 pandemic has presented enormous challenges to the American health care system, and prioritizing the well-being of frontline clinicians is paramount. Even before the pandemic, nearly half of US physicians reported experiencing burnout, with pulmonologists reporting a rate of 41%.

In this special issue of Clinical Perspectives, CHEST is providing a preview of research undertaken by a team of clinicians and social scientists at the University of Minnesota to explore burnout and moral distress among health care providers in ICU and acute care settings during the COVID-19 pandemic.


Monoclonal Antibodies for Treating Patients With COVID-19

These investigational medications—approved for emergency use in patients by the FDA—may reduce progression to severe disease and shorten recovery in high-risk patients. Understand the types of monoclonal antibodies currently available in the US, indications for use, mechanisms of action, and NIH guidelines for this therapy.

Supported by Regeneron


Anti-SARS-CoV-2 Monoclonal Antibodies (mAb)

CHEST COVID-19 Task Force

The mission of the CHEST COVID-19 Task Force--made up of CHEST experts across our Networks in Chest Infections, Critical Care, and Disaster Response and Global Health--is to ensure that CHEST properly supports our community in this time of need. Through the development of educational resources and advice, this group aims to provide meaningful and complementary guidance to that emerging from the CDC and from your local settings. Please keep us apprised of your needs. We welcome input and ask that you contact us via to tell us how we can best support you.

Card image cap

Ryan Maves, MD, FCCP

COVID-19 Task Force, Chair
Disaster Response and Global Health Network, Vice-Chair

Card image cap

Christopher Carroll, MD, FCCP

Critical Care Network, Chair
Social Media Work Group, Co-Chair

Card image cap

Neha S. Dangayach, MD

Social Media Work Group, Member

Card image cap

Jeffrey Dichter, MD, FCCP

Task Force on Mass Critical Care, Chair

Card image cap

Alice Gallo De Moraes, MD

Social Media Work Group, Member

Viren Kaul, MD, FCCP

Viren Kaul, MD, FCCP

Innovations Subcommittee Member

Card image cap

Holly Keyt, MD, FCCP

Chest Infections Network, Vice-Chair

Card image cap

Septimiu Murgu, MD, FCCP

Education Committee, Chair

Card image cap

Marcos Restrepo, MD, PhD, FCCP

Chest Infections Network, Chair

Card image cap

Steven Q. Simpson, MD, FCCP

Board of Regents, President

Supporter Recognition

The following companies have provided unrestricted financial support for CHEST's COVID-19 activities.

Genentech, a member of the Roche Group
Sanofi Genzyme Regeneron

Media resources

Searching for a subject matter expert to speak with you for an article or other media on COVID-19? Need vetted, reliable data for your story? Access to the journal CHEST? We can help. Please contact to speak with our team of experts.